Mild tenderness at the injection site is normal and temporary
Overall recall (sensitivity) was 331/405 (81.7%) for detecting no/mild degeneration, 1,134/1,410 (80.4%) for moderate degeneration, and 18/21 (85.7%) for severe degeneration
Why BPC-157 Peptide Capsules Are Gaining Popularity The rising interest in oral BPC-157 peptide supplements stems from growing awareness of regenerative medicine and non-invasive recovery tools
Stop use and consult a healthcare provider if you experience severe allergic reactions (difficulty breathing, significant swelling, hives spreading beyond the injection site), chest pain or palpitations, severe or persistent gastrointestinal symptoms, or any symptom that concerns you significantly
Human clinical trials for BPC-157 have not been conducted as of 2026
Effects of oral gamma-aminobutyric acid (GABA) administration on stress and sleep in humans: a systematic review